Indirizzo: Via Portuense, 292     Telefono: +39 06.55170.1    

Pubblicazioni 2017

Produzione Scientifica 2017

  1. AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord; AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord (… Antinori A …). Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study. Clin Infect Dis. 2017 Oct 15;65(8):1316-1326. doi: 10.1093/cid/cix480
  2. Amendola A, Bibbolino G, Navarra A, Pisciotta M, Marsella P, Pinnetti C, Abbate I, Rozera G, Mondi A, Antinori A, Capobianchi MR, Girardi E, Ammassari A. Slow or fast viral load decay as a predictor of residual viremia level in HIV-infected patients undergoing successful first-line cART. New Microbiol. 2017 Oct;40(4):234-241.
  3. Amicosante M, D’Ambrosio L, Munoz M, Mello FCQ, Tebruegge M, Chegou NN, Seghrouchni F, Centis R, Goletti D, Bothamley G, Migliori GB; TB Diagnostic Survey Working Group. Current use and acceptability of novel diagnostic tests for active tuberculosis: a worldwide survey. J Bras Pneumol. 2017 Sep-Oct;43(5):380-392. doi: 10.1590/s1806-37562017000000219
  4. Andreoni M, Mussi C, Bellagamba R, Di Campli F, Montinaro V, Babiloni C. Biomarkers of monitoring and functional reserve of physiological systems over time in HIV: expert opinions for effective secondary prevention. New Microbiol. 2017 Oct 10;40(4). [Epub ahead of print]
  5. Antinori A, Di Biagio A, Marcotullio S, Andreoni M, Chirianni A, d’Arminio Monforte A, Galli M, Mazzotta F, Mussini C, Puoti M, Lazzarin A; Italian HIV Guidelines Working Group. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016. New Microbiol. 2017 Apr;40(2):86-98.
  6. Antonioli M, Ciccosanti F, Dengjel J, Fimia GM. Methods to Study the BECN1 Interactome in the Course of Autophagic Responses. Methods Enzymol. 2017;587:429-445. doi: 10.1016/bs.mie.2016.09.069. Epub 2016 Dec 15. doi: 10.1016/bs.mie.2016.09.069
  7. Badia JM, Casey AL, Petrosillo N, Hudson PM, Mitchell SA, Crosby C. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect. 2017 May;96(1):1-15. Epub 2017 Mar 8. doi: 10.1016/j.jhin.2017.03.004
  8. Bartoletti M, Giannella M, Lewis R, Caraceni P, Tedeschi S, Paul M, Schramm C, Bruns T, Merli M, Cobos-Trigueros N, Seminari E, Retamar P, Muñoz P, Tumbarello M, Burra P, Torrani Cerenzia M, Barsic B, Calbo E, Maraolo AE, Petrosillo N, Galan-Ladero MA, D’Offizi G, Bar Sinai N, Rodríguez-Baño J, Verucchi G, Bernardi M, Viale P; ESGBIS/BICHROME study group. A Prospective Multicentre Study of the Epidemiology and Outcomes of Bloodstream Infection in Cirrhotic Patients. Clin Microbiol Infect. 2017 Aug 14. pii: S1198-743X(17)30426-3. [Epub ahead of print] doi: 10.1016/j.cmi.2017.08.001
  9. Bartolini B, Giombini E, Taibi C, Lionetti R, Montalbano M, Visco-Comandini U, D’Offizi G, Capobianchi MR, McPhee F, Garbuglia AR. Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3° Treated with Direct-Acting Antiviral Agents. Viruses. 2017 Aug 7;9(8). pii: E212. doi: 10.3390/v9080212
  10. Bassetti M, Carnelutti A, Muser D, Righi E, Petrosillo N, Di Gregorio F, Werner TJ, Alavi A. 18F-Fluorodeoxyglucose positron emission tomography and infectious diseases: current applications and future perspectives. Curr Opin Infect Dis. 2017 Apr;30(2):192-200. doi: 10.1097/QCO.0000000000000354
  11. Bedenić B, Vranić-Ladavac M, Venditti C, Tambić-Andrašević A, Barišić N, Gužvinec M, Karčić N, Petrosillo N, Ladavac R, Di Caro A. Emergence of colistin resistance in Enterobacter aerogenes from Croatia. J Chemother. 2017 Oct 24:1-4. [Epub ahead of print] doi: 10.1080/1120009X.2017.1382121
  12. Belvisi V, Martellucci S, Garbuglia AR, Del Borgo C, Martellucci S, Baiocchini A, Manicone AM, Bagni O, Mastroianni CM, Gallo A. Case report: human papilloma virus type 120-related papillomatosis mimicking laryngeal carcinoma. Infection. 2017 Oct;45(5):709-713. Epub 2017 May 22 doi: 10.1007/s15010-017-1028-x
  13. Bénet T, Sánchez Picot V, Messaoudi M, Chou M, Eap T, Wang J, Shen K, Pape JW, Rouzier V, Awasthi S, Pandey N, Bavdekar A, Sanghavi S, Robinson A, Rakoto-Andrianarivelo M, Sylla M, Diallo S, Nymadawa P, Naranbat N, Russomando G, Basualdo W, Komurian-Pradel F, Endtz H, Vanhems P, Paranhos-Baccalà G; Global Approach to Biological Research, Infectious diseases and Epidemics in Low-income countries (GABRIEL) Network (… Goletti D …). Microorganisms Associated With Pneumonia in Children <5 Years of Age in Developing and Emerging Countries: The GABRIEL Pneumonia Multicenter, Prospective, Case-Control Study. Clin Infect Dis. 2017 Aug 15;65(4):604-612. doi: 10.1093/cid/cix378
  14. Beninati S, Piacentini M, Bergamini CM. Transglutaminase 2, a double face enzyme. Amino Acids. 2017 Mar;49(3):415-423. doi: 10.1007/s00726-017-2394-5
  15. Biava M, Caglioti C, Bordi L, Castilletti C, Colavita F, Quartu S, Nicastri E, Lauria FN, Petrosillo N, Lanini S, Hoenen T, Kobinger G, Zumla A, Di Caro A, Ippolito G, Capobianchi MR, Lalle E. Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient. PLoS Pathog. 2017 Jan 5;13(1):e1006065. doi: 10.1371/journal.ppat.1006065
  16. Biava M, Caglioti C, Castilletti C, Bordi L, Carletti F, Colavita F, Quartu S, Nicastri E, Iannetta M, Vairo F, Liuzzi G, Taglietti F, Ippolito G, Capobianchi MR, Lalle E. Persistence of ZIKV-RNA in the cellular fraction of semen is accompanied by a surrogate-marker of viral replication. Diagnostic implications for sexual transmission. New Microbiol. 2017 Nov 7;40(4). [Epub ahead of print]
  17. Biava M, Colavita F, Marzorati A, Russo D, Pirola D, Cocci A, Petrocelli A, Delli MG, Cataldi G, Kamara TA, Kamara AS, Konneh K, Cannas A, Coen S, Quartu S, Meschi S, Valli MB, Mazzarelli A, Venditti C, Grassi G, Rozera G, Castilletti C, Mirazimi A, Capobianchi MR, Ippolito G, Miccio R, Di Caro A. Evaluation of a rapid and sensitive RT-qPCR assay for the detection of Ebola Virus. J Virol Methods. 2017 Nov 20. pii: S0166-0934(17)30500-1. [Epub ahead of print] doi: 10.1016/j.jviromet.2017.11.009
  18. Bibas M. Sickle Cell Disease. N Engl J Med. 2017 Jul 20;377(3):303-304. doi: 10.1056/NEJMc1706325
  19. Blasi F, Matteelli A, Sotgiu G, Cirillo DM, Palmieri F, Fattorini L, Migliori GB. Moving towards tuberculosis elimination: a call for action from Italy and a possible model for other low tuberculosis incidence countries. Eur Respir J. 2017 Feb 2;49(2). pii: 1602242 doi: 10.1183/13993003.02242-2016
  20. Bordoni V, Bibas M, Viola D, Sacchi A, Cimini E, Tumino N, Casetti R, Amendola A, Ammassari A, Agrati C, Martini F. Bone Marrow CD34(+) Progenitor Cells from HIV-Infected Patients Show an Impaired T Cell Differentiation Potential Related to Proinflammatory Cytokines. AIDS Res Hum Retroviruses. 2017 Jun;33(6):590-596. Epub 2017 Feb 22. doi: 10.1089/AID.2016.0195
  21. Borges ÁH, Hoy J, Florence E, Sedlacek D, Stellbrink HJ, Uzdaviniene V, Tomazic J, Gargalianos-Kakolyris P, Schmid P, Orkin C, Pedersen C, Leen C, Pradier C, Mulcahy F, Ridolfo AL, Staub T, Maltez F, Weber R, Flamholc L, Kyselyova G, Lundgren JD, Mocroft A; for EuroSIDA (… Zaccarelli M, Antinori A, Acinapura R, Plazzi M …). Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort. Clin Infect Dis. 2017 May 15;64(10):1413-1421. doi: 10.1093/cid/cix167
  22. Borisov SE, Dheda K, Enwerem M, Romero Leyet R, D’Ambrosio L, Centis R, Sotgiu G, Tiberi S, Alffenaar JW, Maryandyshev A, Belilovski E, Ganatra S, Skrahina A, Akkerman O, Aleksa A, Amale R, Artsukevich J, Bruchfeld J, Caminero JA, Carpena Martinez I, Codecasa L, Dalcolmo M, Denholm J, Douglas P, Duarte R, Esmail A, Fadul M, Filippov A, Davies Forsman L, Gaga M, Garcia-Fuertes JA, García-García JM, Gualano G, Jonsson J, Kunst H, Lau JS, Lazaro Mastrapa B, Teran Troya JL, Manga S, Manika K, González Montaner P, Mullerpattan J, Oelofse S, Ortelli M, Palmero DJ, Palmieri F, Papalia A, Papavasileiou A, Payen MC, Pontali E, Robalo Cordeiro C, Saderi L, Sadutshang TD, Sanukevich T, Solodovnikova V, Spanevello A, Topgyal S, Toscanini F, Tramontana AR, Farokh Udwadia Z, Viggiani P, White V, Zumla A, Migliori GB. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. Eur Respir J. 2017 May 21;49(5). pii: 1700387. Print 2017 May. doi: 10.1183/13993003.00387-2017
  23. Bothamley GH, Lange C; TBNET (… Palmieri F …). Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study. Respir Med. 2017 Nov;132:68-75. Epub 2017 Sep 23. doi: 10.1016/j.rmed.2017.09.007
  24. Brancaccio G, Sorbo MC, Frigeri F, Rizzo V, Cantone M, Genderini F, Fabeni L, Pinto A, Perno CF, Ceccherini-Silberstein F, Gaeta GB. Treatment of Acute Hepatitis C With Ledipasvir and Sofosbuvir in Patients With Hematological Malignancies Allows Early Re-start of Chemotherapy. Clin Gastroenterol Hepatol. 2017 Nov 28. pii: S1542-3565(17)31299-5. [Epub ahead of print] doi: 10.1016/j.cgh.2017.10.032
  25. Cahn P, Kaplan R, Sax PE, Squires K, Molina JM, Avihingsanon A, Ratanasuwan W, Rojas E, Rassool M, Bloch M, Vandekerckhove L, Ruane P, Yazdanpanah Y, Katlama C, Xu X, Rodgers A, East L, Wenning L, Rawlins S, Homony B, Sklar P, Nguyen BY, Leavitt R, Teppler H; ONCEMRK Study Group (… Antinori A …). Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial. Lancet HIV. 2017 Nov;4(11):e486-e494. Epub 2017 Sep 11. doi: 10.1016/S2352-3018(17)30128-
  26. Camassa S, Palucci I, Iantomasi R, Cubeddu T, Minerva M, De Maio F, Jouny S, Petruccioli E, Goletti D, Ria F, Sali M, Sanguinetti M, Manganelli R, Rocca S, Brodin P, Delogu G. Impact of pe_pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis. Front Cell Infect Microbiol. 2017 Apr 21;7:137. eCollection 2017. doi: 10.3389/fcimb.2017.00137
  27. Cantini F, Nannini C, Niccoli L, Petrone L, Ippolito G, Goletti D. Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics. Mediators Inflamm. 2017;2017:8909834. Epub 2017 Jun 1. doi: 10.1155/2017/8909834
  28. Cantini F, Niccoli L, Nannini C, Cassarà E, Kaloudi O, Giulio Favalli E, Becciolini A, Benucci M, Gobbi FL, Guiducci S, Foti R, Mosca M, Goletti D. Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Semin Arthritis Rheum. 2017 Oct;47(2):183-192. Epub 2017 Mar 22. doi: 10.1016/j.semarthrit.2017.03.008
  29. Cardeti G, Gruber CEM, Eleni C, Carletti F, Castilletti C, Manna G, Rosone F, Giombini E, Selleri M, Lapa D, Puro V, Di Caro A, Lorenzetti R, Scicluna MT, Grifoni G, Rizzoli A, Tagliapietra V, De Marco L, Capobianchi MR, Autorino GL. Fatal Outbreak in Tonkean Macaques Caused by Possibly Novel Orthopoxvirus, Italy, January 2015(1). Emerg Infect Dis. 2017 Dec 15;23(12). [Epub ahead of print] doi: 10.3201/eid2312.162098
  30. Carrai P, Morelli C, Cordone G, Romano A, Tamé M, Lionetti R, Pietrosi G, Lenci I, Piai G, Russo FP, Coppola C, Melazzini M, Montilla S, Pani L, Petraglia S, Russo P, Trotta MP, Martini S, Toniutto P; ITACOPS study group. The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes. Transpl Int. 2017 Dec;30(12):1253-1265. Epub 2017 Sep 7. doi: 10.1111/tri.13018
  31. Casadellà M, Cozzi-Lepri A, Phillips A, Noguera-Julian M, Bickel M, Sedlacek D, Zilmer K, Clotet B, Lundgren JD, Paredes R; EuroSIDA in EuroCOORD (… Zaccarelli M, Antinori A, Acinapura R, Plazzi M …). Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death. PLoS One. 2017 Jan 27;12(1):e0166613. eCollection 2017. doi: 10.1371/journal.pone.0166613
  32. Casetti R, Pinnetti C, Sacchi A, De Simone G, Bordoni V, Cimini E, Tumino N, Besi F, Viola D, Turchi F, Mazzotta V, Antinori A, Martini F, Ammassari A, Agrati C. HIV-Specific CD8 T Cells Producing CCL-4 Are Associated With Worse Immune Reconstitution During Chronic Infection. J Acquir Immune Defic Syndr. 2017 Ju1;75(3):338-344. doi: 10.1097/QAI.0000000000001392
  33. Castagna A, Ferrara M, Galli L, Comi L, Sterrantino G, Cenderello G, Zaccarelli M, Focà E, Roncadori A, Lazzarin A; PRESTIGIO Study Group. Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus. J Antimicrob Chemother. 2017 Oct 24. [Epub ahead of print] doi: 10.1093/jac/dkx371
  34. Cataldo MA, Granata G, Petrosillo N. Antibacterial Prophylaxis for Surgical Site Infection in the Elderly: Practical Application. Drugs Aging. 2017 Jul;34(7):489-498. doi: 10.1007/s40266-017-0471-9
  35. Cataldo MA, Granata G, Petrosillo N. Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship. Expert Rev Anti Infect Ther. 2017 Nov;15(11):1027-1040. Epub 2017 Oct 9. doi: 10.1080/14787210.2017.1387535
  36. Chereau F, Madec Y, Sabin C, Obel N, Ruiz-Mateos E, Chrysos G, Fidler S, Lehmann C, Zangerle R, Wittkop L, Reiss P, Hamouda O, Estrada Perez V, Leal M, Mocroft A, Garcia De Olalla P, Ammassari A, D’Arminio Monforte A, Mussini C, Segura F, Castagna A, Cavassini M, Grabar S, Morlat P, De Wit S, Lambotte O, Meyer L; HIV Controllers Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCOORD. Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers. PLoS One. 2017 Apr 5;12(4):e0173893. eCollection 2017. doi: 10.1371/journal.pone.0173893
  37. Chiacchio T, Delogu G, Vanini V, Cuzzi G, De Maio F, Pinnetti C, Sampaolesi A, Antinori A, Goletti D. Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection. PLoS One. 2017 Aug 24;12(8):e0183846. eCollection 2017. doi: 10.1371/journal.pone.0183846
  38. Chimenti C, Verardo R, Scopelliti F, Grande C, Petrosillo N, Piselli P, De Paulis R, Frustaci A. Myocardial expression of Toll-like receptor 4 predicts the response to immunosuppressive therapy in patients with virus-negative chronic inflammatory cardiomyopathy. Eur J Heart Fail. 2017 Jul;19(7):915-925. Epub 2017 Mar 31. doi: 10.1002/ejhf.796
  39. Chinello P, Petrosillo N, Pittalis S, Biava G, Ippolito G, Nicastri E; INMI Ebola Team. QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient. PLoS Negl Trop Dis. 2017 Dec 28;11(12):e0006034. eCollection 2017 Dec. doi: 10.1371/journal.pntd.0006034
  40. Cimini E, Bordoni V, Sacchi A, Visco-Comandini U, Montalbano M, Taibi C, Casetti R, Lalle E, D’Offizi G, Capobianchi MR, Agrati C. Intrahepatic Vγ9Vδ2 T-cells from HCV-infected patients show an exhausted phenotype but can inhibit HCV replication. Virus Res. 2017 Oct 10;243:31-35. [Epub ahead of print] doi: 10.1016/j.virusres.2017.10.008
  41. Cimini E, Castilletti C, Sacchi A, Casetti R, Bordoni V, Romanelli A, Turchi F, Martini F, Tumino N, Nicastri E, Corpolongo A, Di Caro A, Kobinger G, Zumla A, Capobianchi MR, Ippolito G, Agrati C. Human Zika infection induces a reduction of IFN-γ producing CD4 T-cells and a parallel expansion of effector Vδ2 T-cells. Sci Rep. 2017 Jul 24;7(1):6313. doi: 10.1038/s41598-017-06536-x
  42. Cimini E, Viola D, Cabeza-Cabrerizo M, Romanelli A, Tumino N, Sacchi A, Bordoni V, Casetti R, Turchi F, Martini F, Bore JA, Koundouno FR, Duraffour S, Michel J, Holm T, Zekeng EG, Cowley L, Garcia Dorival I, Doerrbecker J, Hetzelt N, Baum JHJ, Portmann J, Wölfel R, Gabriel M, Miranda O, Díaz G, Díaz JE, Fleites YA, Piñeiro CA, Castro CM, Koivogui L, Magassouba N, Diallo B, Ruibal P, Oestereich L, Wozniak DM, Lüdtke A, Becker-Ziaja B, Capobianchi MR, Ippolito G, Carroll MW, Günther S, Di Caro A, Muñoz-Fontela C, Agrati C. Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections. PLoS Negl Trop Dis. 2017 May 30;11(5):e0005645. [Epub ahead of print] doi: 10.1371/journal.pntd.0005645
  43. Cingolani A, Cozzi Lepri A, Teofili L, Galli L, Mazzotta V, Baldin GM, Hohaus S, Bandera A, Alba L, Galizzi N, Castagna A, D’arminio Monforte A, Antinori A; ICONA Foundation Study group. Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population. PLoS One. 2017 Oct 31;12(10):e0186549. eCollection 2017. doi: 10.1371/journal.pone.0186549
  44. Colaceci S, Giusti A, Chapin EM, Bettinelli ME, De Angelis A, Zambri F, Vellone E, Alvaro R, De Mei B. E-learning to Improve Healthcare Professionals’ Attitudes and Practices on Breastfeeding. Breastfeed Med. 2017 Dec;12(10):629-636. Epub 2017 Sep 19. doi: 10.1089/bfm.2017.0060
  45. Colavita F, Biava M, Castilletti C, Quartu S, Vairo F, Caglioti C, Agrati C, Lalle E, Bordi L, Lanini S, Guanti MD, Miccio R, Ippolito G, Capobianchi MR, Di Caro A; Lazzaro Spallanzani Institute for Research and Health Care Ebola Virus Disease Sierra Leone Study Group.. Measles Cases during Ebola Outbreak, West Africa, 2013-2106. Emerg Infect Dis. 2017 Jun;23(6):1035-1037. doi: 10.3201/eid2306.161682
  46. Colavita F, Biava M, Mertens P, Gilleman Q, Borlon C, Guanti MD, Petrocelli A, Cataldi G, Kamara AT, Kamara SA, Konneh K, Vincenti D, Castilletti C, Abdurahman S, Mirazimi A, Capobianchi MR, Ippolito G, Miccio R, Di Caro A. EBOLA Ag K-SeT rapid test: field evaluation in Sierra Leone. Clin Microbiol Infect. 2017 Oct 26. pii: S1198-743X(17)30581-5. [Epub ahead of print] doi: 10.1016/j.cmi.2017.10.019
  47. Costa V, Lo Dico A, Rizzo A, Rajata F, Tripodi M, Alessandro R, Conigliaro A. MiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cells. Oncotarget. 2017 Apr 11;8(15):24292-24302. doi: 10.18632/oncotarget.14464
  48. Costanzo G, Giorgi A, Scipioni A, Timperio AM, Mancone C, Tripodi M, Kapralov M, Krasavin E, Kruse H, Šponer J, Šponer JE, Ranc V, Otyepka M, Pino S, Di Mauro E. Nonenzymatic Oligomerization of 3′,5′-Cyclic CMP Induced by Proton and UV Irradiation Hints at a Nonfastidious Origin of RNA. Chembiochem. 2017 Aug 4;18(15):1535-1543. Epub 2017 Jun 30. doi: 10.1002/cbic.201700122
  49. Cozzi-Lepri A, Zangerle R, Machala L, Zilmer K, Ristola M, Pradier C, Kirk O, Sambatakou H, Fätkenheuer G, Yust I, Schmid P, Gottfredsson M, Khromova I, Jilich D, Flisiak R, Smidt J, Rozentale B, Radoi R, Losso MH, Lundgren JD, Mocroft A; EuroSIDA Study Group (… Zaccarelli M, Antinori A, Acinapura R, Plazzi M …). Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens. HIV Med. 2017 Oct 6. [Epub ahead of print] doi: 10.1111/hiv.12557
  50. Cuypers L, Vrancken B, Fabeni L, Marascio N, Cento V, Di Maio VC, Aragri M, Pineda-Peña AC, Schrooten Y, Van Laethem K, Balog D, Focà A, Torti C, Nevens F, Perno CF, Vandamme AM, Ceccherini-Silberstein F. Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy. BMC Evol Biol. 2017 Mar 7;17(1):70. doi: 10.1186/s12862-017-0913-3
  51. d’Arminio Monforte A, Cozzi-Lepri A, Ceccherini-Silberstein F, De Luca A, Lo Caputo S, Castagna A, Mussini C, Cingolani A, Tavelli A, Shanyinde M, Gori A, Girardi E, Andreoni M, Antinori A, Puoti M; Icona Foundation and HepaIcona Study Group. Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort. PLoS One. 2017 May 17;12(5):e0177402. eCollection 2017. doi: 10.1371/journal.pone.0177402
  52. De Luca A, Lorenzini P, Castagna A, Puoti M, Gianotti N, Castelli F, Mastroianni C, Maggiolo F, Antinori A, Guaraldi G, Lichtner M, d’Arminio Monforte A; ICONA Foundation Study. Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated With Incident and Prevalent Type 2 Diabetes in Persons Living With HIV. J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):465-471. doi: 10.1097/QAI.0000000000001443
  53. De Wit S, Battegay M, D’Arminio Monforte A, Lundgren JD, Oprea C, Antinori A, Bhagani S, Fätkenheuer G, Friis-Moller N, Furrer H, Mussini C; European AIDS Clinical Society. European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16-17 November 2016: a summary. HIV Med. 2017 Oct 27. [Epub ahead of print] doi: 10.1111/hiv.12559
  54. Dedicoat MJ, Günther G, Crudu V, Duarte R, Gualano G, Magis-Escurra C, Rumetshofer R, Skrahina A, Spinu V, Tiberi S, Viiklepp P, van Leth F, Lange C; TBNET. Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure. Am J Respir Crit Care Med. 2017 Nov 1;196(9):1222-1224 doi: 10.1164/rccm.201612-2585LE
  55. Del Borgo C, Belvisi V, Valli MB, Currà A, Pozzetto I, Sepe M, Mastroianni CM. Diplopia as isolated presentation of varicella zoster central nervous system reactivation. J Neurovirol. 2017 Aug;23(4):621-624. Epub 2017 May 30. doi: 10.1007/s13365-017-0534-z
  56. Di Biagio A, Lorenzini P, Gustinetti G, Rusconi S, De Luca A, Lapadula G, Lo Caputo S, Cicalini S, Castelli F, Marchetti G, Antinori A, Monforte AD. Durability of Second Antiretroviral Regimens in the Italian Cohort Naïve Antiretrovirals Foundation Study and Factors Associated with Discontinuation. AIDS Patient Care STDS. 2017 Dec;31(12):487-494. doi: 10.1089/apc.2017.0140
  57. Di Giambenedetto S, Fabbiani M, Quiros Roldan E, Latini A, D’Ettorre G, Antinori A, Castagna A, Orofino G, Francisci D, Chinello P, Madeddu G, Grima P, Rusconi S, Di Pietro M, Mondi A, Ciccarelli N, Borghetti A, Focà E, Colafigli M, De Luca A, Cauda R; Atlas-M Study Group. Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M). J Antimicrob Chemother. 2017 Apr 1;72(4):1163-1171. doi: 10.1093/jac/dkw557
  58. Dirani G, Paesini E, Mascetra E, Farabegoli P, Dalmo B, Bartolini B, Garbuglia AR, Capobianchi MR, Sambri V. A novel next generation sequencing assay as an alternative to currently available methods for hepatitis C virus genotyping. J Virol Methods. 2017 Oct 16;251:88-91. [Epub ahead of print] doi: 10.1016/j.jviromet.2017.10.005
  59. D’Offizi G, Cammà C, Taibi C, Schlag M, Weber K, Palma M, DeMasi R, Janssen K, Witek J, Lionetti R. Clinical and virological predictors of sustained response with an interferon-based simeprevir regimen for patients with chronic genotype 1 hepatitis C virus infection. New Microbiol. 2017 Jan;40(1):19-26. Epub 2017 Jan 9.
  60. Dudas G, Carvalho LM, Bedford T, Tatem AJ, Baele G, Faria NR, Park DJ, Ladner JT, Arias A, Asogun D, Bielejec F, Caddy SL, Cotten M, D’Ambrozio J, Dellicour S, Di Caro A, Diclaro JW, Duraffour S, Elmore MJ, Fakoli LS, Faye O, Gilbert ML, Gevao SM, Gire S, Gladden-Young A, Gnirke A, Goba A, Grant DS, Haagmans BL, Hiscox JA, Jah U, Kugelman JR, Liu D, Lu J, Malboeuf CM, Mate S, Matthews DA, Matranga CB, Meredith LW, Qu J, Quick J, Pas SD, Phan MVT, Pollakis G, Reusken CB, Sanchez-Lockhart M, Schaffner SF, Schieffelin JS, Sealfon RS, Simon-Loriere E, Smits SL, Stoecker K, Thorne L, Tobin EA, Vandi MA, Watson SJ, West K, Whitmer S, Wiley MR, Winnicki SM, Wohl S, Wölfel R, Yozwiak NL, Andersen KG, Blyden SO, Bolay F, Carroll MW, Dahn B, Diallo B, Formenty P, Fraser C, Gao GF, Garry RF, Goodfellow I, Günther S, Happi CT, Holmes EC, Kargbo B, Keïta S, Kellam P, Koopmans MPG, Kuhn JH, Loman NJ, Magassouba N, Naidoo D, Nichol ST, Nyenswah T, Palacios G, Pybus OG, Sabeti PC, Sall A, Ströher U, Wurie I, Suchard MA, Lemey P, Rambaut A. Virus genomes reveal factors that spread and sustained the Ebola epidemic. Nature. 2017 Apr 20;544(7650):309-315. Epub 2017 Apr 12. doi: 10.1038/nature22040
  61. Efsen AMW, Schultze A, Miller RF, Panteleev A, Skrahin A, Podlekareva DN, Miro JM, Girardi E, Furrer H, Losso MH, Toibaro J, Caylà JA, Mocroft A, Lundgren JD, Post FA, Kirk O; TB: HIV study in EuroCoord. Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study. J Infect. 2017 Oct 20. pii: S0163-4453(17)30320-1. [Epub ahead of print] doi: 10.1016/j.jinf.2017.10.007
  62. Esposito S, Bassetti M, Concia E, De Simone G, De Rosa FG, Grossi P, Novelli A, Menichetti F, Petrosillo N, Tinelli M, Tumbarello M, Sanguinetti M, Viale P, Venditti M, Viscoli C; Italian Society of Infectious and Tropical Diseases. Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update. J Chemother. 2017 Aug;29(4):197-214. Epub 2017 Apr 5. doi: 10.1080/1120009X.2017.1311398
  63. Fabbri G, Mastrorosa I, Vergori A, Mazzotta V, Pinnetti C, Grisetti S, Zaccarelli M, Ammassari A, Antinori A. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature. BMC Infect Dis. 2017 Mar 1;17(1):182. doi: 10.1186/s12879-017-2287-y
  64. Fabeni L, Alteri C, Di Carlo D, Orchi N, Carioti L, Bertoli A, Gori C, Forbici F, Continenza F, Maffongelli G, Pinnetti C, Vergori A, Mondi A, Ammassari A, Borghi V, Giuliani M, De Carli G, Pittalis S, Grisetti S, Pennica A, Mastroianni CM, Montella F, Cristaudo A, Mussini C, Girardi E, Andreoni M, Antinori A, Ceccherini-Silberstein F, Perno CF, Santoro MM; SENDIH Study Group; SENDIH (Studio Epidemiologico Nuove Diagnosi Infezione da HIV) Study Group. Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14. J Antimicrob Chemother. 2017 Oct 1;72(10):2837-2845. doi: 10.1093/jac/dkx231
  65. Fabeni L, Berno G, Fokam J, Bertoli A, Alteri C, Gori C, Forbici F, Takou D, Vergori A, Zaccarelli M, Maffongelli G, Borghi V, Latini A, Pennica A, Mastroianni CM, Montella F, Mussini C, Andreoni M, Antinori A, Perno CF, Santoro MM; Resistance Study Group. Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains. J Clin Microbiol. 2017 Sep;55(9):2827-2837. Epub 2017 Ju12. doi: 10.1128/JCM.00656-17
  66. Faccenda D, Nakamura J, Gorini G, Dhoot GK, Piacentini Md, Yoshida M, Campanella M. Control of Mitochondrial Remodeling by the ATPase Inhibitory Factor 1 Unveils a Pro-survival Relay via OPA1. Cell Rep. 2017 Feb 21;18(8):1869-1883. doi: 10.1016/j.celrep.2017.01.070
  67. Fausther-Bovendo H, Qiu X, McCorrister S, Westmacott G, Sandstrom P, Castilletti C, Di Caro A, Ippolito G, Kobinger GP. Ebola virus infection induces autoimmunity against dsDNA and HSP60. Sci Rep. 2017 Feb 9;7:42147. doi: 10.1038/srep42147
  68. Floridia M, Frisina V, Ravizza M, Marconi AM, Pinnetti C, Cetin I, Sansone M, Molinari A, Cervi F, Meloni A, Luzi K, Masuelli G, Tamburrini E; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy. Evolving treatment implementation among HIV-infected pregnant women and their partners: results from a national surveillance study in Italy, 2001-2015. J Glob Health. 2017 Jun;7(1):010407. doi: 10.7189/jogh.07.010407
  69. Floridia M, Masuelli G, Ravizza M, Tassis B, Cetin I, Sansone M, Degli Antoni A, Simonazzi G, Maccabruni A, Francisci D, Frisina V, Liuzzi G, Dalzero S, Tamburrini E; Italian Group on Surveillance of Antiretroviral Treatment in Pregnancy. Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study. J Antimicrob Chemother. 2017 Dec 13. [Epub ahead of print] doi: 10.1093/jac/dkx478
  70. Floridia M, Masuelli G, Tamburrini E, Cetin I, Liuzzi G, Martinelli P, Guaraldi G, Spinillo A, Vimercati A, Maso G, Pinnetti C, Frisina V, Dalzero S, Ravizza M. Pregnant with HIV before age 25: data from a large national study in Italy, 2001-2016. Epidemiol Infect. 2017 Aug;145(11):2360-2365. doi: 10.1017/S0950268817001340
  71. Fortuna C, Remoli ME, Rizzo C, Benedetti E, Fiorentini C, Bella A, Argentini C, Farchi F, Castilletti C, Capobianchi MR, Zammarchi L, Bartoloni A, Zanchetta N, Gismondo MR, Nelli LC, Vitale G, Baldelli F, D’Agaro P, Sodano G, Rezza G; Arbovirus Working Group, Venturi G. Imported arboviral infections in Italy, July 2014-October 2015: a National Reference Laboratory report. BMC Infect Dis. 2017 Mar 16;17(1):216. Erratum in: BMC Infect Dis. 2017 May 10;17 (1):335. doi: 10.1186/s12879-017-2320-1
  72. Fosso B, Santamaria M, D’Antonio M, Lovero D, Corrado G, Vizza E, Passaro N, Garbuglia AR, Capobianchi MR, Crescenzi M, Valiente G, Pesole G. MetaShot: an accurate workflow for taxon classification of host-associated microbiome from shotgun metagenomic data. Bioinformatics. 2017 Jun 1;33(11):1730-1732. doi: 10.1093/bioinformatics/btx036
  73. Frustaci A, Letizia C, Adamo F, Grande C, Verardo R, Chimenti C. A-V block as presentation of cardiac amyloid: prominent infiltration of conduction tissue revealed by endomyocardial biopsy. Amyloid. 2017 Jun;24(2):131-132. Epub 2017 May 10. doi: 10.1080/13506129.2017.1323735
  74. Gagliardini R, Bandera A, Zaccarelli M, Sterrantino G, Latini A, D’Avino A, Lapadula G, Antinori A, Cauda R, De Luca A, Gori A, Di Giambenedetto S, Fabbiani M. 3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir. Antivir Ther. 2017 Aug 11. [Epub ahead of print] doi: 10.3851/IMP3188
  75. Galea N, Francone M, Fiorelli A, Noce V, Giannetta E, Chimenti C, Frustaci A, Catalano C, Carbone I. Early myocardial gadolinium enhancement in patients with myocarditis: Validation of “Lake Louise consensus” criteria using a single bolus of 0.1mmol/Kg of a high relaxivity gadolinium-based contrast agent. Eur J Radiol. 2017 Oct;95:89-95. Epub 2017 Jul 27. doi: 10.1016/j.ejrad.2017.07.008
  76. Galluzzi L, Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cecconi F, Choi AM, Chu CT, Codogno P, Colombo MI, Cuervo AM, Debnath J, Deretic V, Dikic I, Eskelinen EL, Fimia GM, Fulda S, Gewirtz DA, Green DR, Hansen M, Harper JW, Jäättelä M, Johansen T, Juhasz G, Kimmelman AC, Kraft C, Ktistakis NT, Kumar S, Levine B, Lopez-Otin C, Madeo F, Martens S, Martinez J, Melendez A, Mizushima N, Münz C, Murphy LO, Penninger JM, Piacentini M, Reggiori F, Rubinsztein DC, Ryan KM, Santambrogio L, Scorrano L, Simon AK, Simon HU, Simonsen A, Tavernarakis N, Tooze SA, Yoshimori T, Yuan J, Yue Z, Zhong Q, Kroemer G. Molecular definitions of autophagy and related processes. EMBO J. 2017 Jul 3;36(13):1811-1836. Epub 2017 Jun 8. doi: 10.15252/embj.201796697
  77. Garbuglia AR, Bibbò A, Sciamanna R, Pisciotta M, Capobianchi MR. Performance evaluation of the Aptima(®) HCV Quant Dx assay for hepatitis C virus (HCV) RNA detection and quantification in comparison to the Abbott RealTime HCV assay. J Clin Virol. 2017 Apr 26;92:1-6. [Epub ahead of print] doi: 10.1016/j.jcv.2017.04.013
  78. Gelmetti V, De Rosa P, Torosantucci L, Marini ES, Romagnoli A, Di Rienzo M, Arena G, Vignone D, Fimia GM, Valente EM. PINK1 and BECN1 relocalize at mitochondria-associated membranes during mitophagy and promote ER-mitochondria tethering and autophagosome formation. Autophagy. 2017 Apr 3;13(4):654-669. Epub 2017 Feb 17. doi: 10.1080/15548627.2016.1277309
  79. Ghezzi S, Cooper L, Rubio A, Pagani I, Capobianchi MR, Ippolito G, Pelletier J, Meneghetti MC, Lima MA, Skidmore MA, Broccoli V, Yates EA, Vicenzi E. Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells. Antiviral Res. 2017 Jan 5;140:13-17. [Epub ahead of print] doi: 10.1016/j.antiviral.2016.12.023
  80. Gianotti N, Cozzi-Lepri A, Antinori A, Castagna A, De Luca A, Celesia BM, Galli M, Mussini C, Pinnetti C, Spagnuolo V, d’Arminio Monforte A, Ceccherini-Silberstein F, Andreoni M; Icona Foundation Study and mono-PI/r database Study Cohorts. Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients. PLoS One. 2017 Feb 13;12(2):e0171611. doi: 10.1371/journal.pone.0171611
  81. Gianotti N, Marchetti G, Antinori A, Saracino A, Gori A, Rizzardini G, Lichtner M, Bandera A, Mussini C, Girardi E, Monforte AD, Cozzi-Lepri A; ICONA Foundation Study Group. Drop in CD4+ counts below 200 cells/µL after reaching (or starting from) values higher than 350 cells/µL in HIV-infected patients with virological suppression. J Acquir Immune Defic Syndr. 2017 Dec 1;76(4):417-422. doi: 10.1097/QAI.0000000000001522
  82. Giombini E, Rueca M, Barberi W, Iori AP, Inghilleri M, Castilletti C, Scognamiglio P, Vairo F, Ippolito G, Capobianchi MR, Valli MB. Enterovirus D68-Associated Acute Flaccid Myelitis in Immunocompromised Woman, Italy. Emerg Infect Dis. 2017 Oct;23(10):1690-1693. doi: 10.3201/eid2310.170792
  83. Girardi E, Sañé Schepisi M, Goletti D, Bates M, Mwaba P, Yeboah-Manu D, Ntoumi F, Palmieri F, Maeurer M, Zumla A, Ippolito G. The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications. Int J Infect Dis. 2017 Mar;56:45-53. Epub 2017 Jan 30. doi: 10.1016/j.ijid.2017.01.018
  84. Gourlay A, Noori T, Pharris A, Axelsson M, Costagliola D, Cowan S, Croxford S, d’Arminio Monforte A, Del Amo J, Delpech V, Díaz A, Girardi E, Gunsenheimer-Bartmeyer B, Hernando V, Jose S, Leierer G, Nikolopoulos G, Obel N, Op de Coul E, Paraskeva D, Reiss P, Sabin C, Sasse A, Schmid D, Sonnerborg A, Spina A, Suligoi B, Supervie V, Touloumi G, Van Beckhoven D, van Sighem A, Vourli G, Zangerle R, Porter K; European HIV Continuum of Care Working Group. The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges. Clin Infect Dis. 2017 Jun 15;64(12):1644-1656. doi: 10.1093/cid/cix212
  85. Haddow LJ, Laverick R, Daskalopoulou M, McDonnell J, Lampe FC, Gilson R, Speakman A, Antinori A, Balestra P, Bruun T, Gerstoft J, Nielsen L, Vassilenko A, Collins S, Rodger AJ; Cognitive Impairment in People with HIV in the European Region (CIPHER) Study Group. Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients. AIDS Behav. 2017 Jan 31. [Epub ahead of print] doi: 10.1007/s10461-017-1683-z
  86. Höller K, Fabeni L, Herling M, Holtick U, Scheid C, Knops E, Lübke N, Kaiser R, Pfister H, Di Cristanziano V. Dynamics of BKPyV reactivation and risk of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Eur J Haematol. 2017 Aug;99(2):133-140. Epub 2017 May 30. doi: 10.1111/ejh.12895
  87. Iannetta M, Ippolito G, Nicastri E. Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells. Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e01152-17. Print 2017 Sep. doi: 10.1128/AAC.01152-17
  88. Iannetta M, Lalle E, Musso M, Carletti F, Scorzolini L, D’Abramo A, Chinello P, Castilletti C, Ippolito G, Capobianchi MR, Nicastri E. Persistent detection of dengue virus RNA in vaginal secretion of a woman returning from Sri Lanka to Italy, April 2017. Euro Surveill. 2017 Aug 24;22(34). pii: 30600. doi: 10.2807/1560-7917.ES.2017.22.34.30600
  89. Ippolito G, Bordi L. [Zika emergenza di salute pubblica di rilevanza internazionale: 1 febbraio 2016-18 novembre 2016]. Epidemiol Prev. 2017 Jan-Feb;41(1):3-5. doi: 10.19191/EP17.1.P003.002
  90. Ippolito G, Rezza G. Preface – Emerging Viruses: From Early Detection to Intervention. Adv Exp Med Biol. 2017;972:1-5. doi: 10.1007/5584_2017_33
  91. Jones A, Pitts M, Al Dulayymi JR, Gibbons J, Ramsay A, Goletti D, Gwenin CD, Baird MS. New synthetic lipid antigens for rapid serological diagnosis of tuberculosis. PLoS One. 2017 Aug 14;12(8):e0181414. eCollection 2017. doi: 10.1371/journal.pone.0181414
  92. Kaufmann SHE, Dockrell HM, Drager N, Ho MM, McShane H, Neyrolles O, Ottenhoff THM, Patel B, Roordink D, Spertini F, Stenger S, Thole J, Verreck FAW, Williams A; TBVAC2020 Consortium (… Goletti D …). TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development. Front Immunol. 2017 Oct 4;8:1203. eCollection 2017. doi: 10.3389/fimmu.2017.01203
  93. Kurth F, Develoux M, Mechain M, Malvy D, Clerinx J, Antinori S, Gjørup IE, Gascon J, Mørch K, Nicastri E, Ramharter M, Bartoloni A, Visser L, Rolling T, Zanger P, Calleri G, Salas-Coronas J, Nielsen H, Just-Nübling G, Neumayr A, Hachfeld A, Schmid ML, Antonini P, Lingscheid T, Kern P, Kapaun A, da Cunha JS, Pongratz P, Soriano-Arandes A, Schunk M, Suttorp N, Hatz C, Zoller T. Severe malaria in Europe: an 8-year multi-centre observational study. Malar J. 2017 Jan 31;16(1):57. doi: 10.1186/s12936-016-1673-z
  94. La Manna MP, Orlando V, Dieli F, Di Carlo P, Cascio A, Cuzzi G, Palmieri F, Goletti D, Caccamo N. Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages. PLoS One. 2017 Feb 16;12(2):e0171358. doi: 10.1371/journal.pone.0171358
  95. Lanini S, Minosse C, Vairo F, Garbuglia A, Di Bari V, Agresta A, Rezza G, Puro V, Pendenza A, Loffredo MR, Scognamiglio P, Zumla A, Panella V, Ippolito G, Capobianchi MR; Gruppo Laziale Sorveglianza Epatiti Virali (GLaSEV). A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 – March 2017. PLoS One. 2017 Nov 10;12(11):e0185428. eCollection 2017. doi: 10.1371/journal.pone.0185428
  96. Lanini S, Portella G, Vairo F, Di Caro A, Kobinger G, Zumla A, Ippolito G. Reply to Reisler et al. Clin Infect Dis. 2017 Dec 20. [Epub ahead of print] doi: 10.1093/cid/cix1026
  97. Lanini S, Portella G, Vairo F, Kobinger GP, Pesenti A, Langer M, Kabia S, Brogiato G, Amone J, Castilletti C, Miccio R, Capobianchi MR, Strada G, Zumla A, Di Caro A, Ippolito G; INMI-EMERGENCY EBOV Sierra Leone Study group. Relationship between viremia and specific organ damage in Ebola patients: a cohort study. Clin Infect Dis. 2017 Aug 20. [Epub ahead of print] doi: 10.1093/cid/cix704
  98. Lapa D, Brega C, Mammone A, Zaccarelli M, Capobianchi MR, Garbuglia AR. Diagnostic performance of hepatitis E virus antigen assay in hepatitis E virus acute infection. New Microbiol. 2017 Oct; 40(4):246-250. Epub 2017 Oct 10.
  99. Latini A, Orsini D, Ambrifi M, Colafigli M, Zaccarelli M, Cristaudo A.Classical Kaposi’s Sarcoma (KS) concurrent with Ledipasvir-Sofosbuvir therapy for Hepatitis C infection (HCV). G Ital Dermatol Venereol. 2017 Nov 30. [Epub ahead of print] doi: 10.23736/S0392-0488.17.05788-1
  100. Latini A, Zaccarelli M, Paglia MG, Donà MG, Giglio A, Moretto D, Vulcano A, Giuliani M, Colafigli M, Ambrifi M, Pimpinelli F, Cristaudo A. Inguinal and anorectal Lymphogranuloma Venereum: a case series from a sexually transmitted disease center in Rome, Italy. BMC Infect Dis. 2017 Jun 2;17(1):386. doi: 10.1186/s12879-017-2484-8
  101. Laverick R, Haddow L, Daskalopoulou M, Lampe F, Gilson R, Speakman A, Antinori A, Bruun T, Vassilenko A, Collins S, Rodger A; Cognitive Impairment in People with HIV in the European Region (CIPHER) Study Group. Self-reported decline in everyday function, cognitive symptoms and cognitive function in people with HIV. J Acquir Immune Defic Syndr. 2017; 76(3):e74-e83. doi: 10.1097/QAI.0000000000001468
  102. Lionetti R, Calvaruso V, Piccolo P, Mancusi RL, Mazzarelli C, Fagiuoli S, Montalbano M, Lenci I, Carrai P, Guaraldi G, Visco-Comandini U, Milana M, Biolato M, Loiacono L, Valente G, Craxì A, Angelico M, D’offizi G. Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: a prospective study. Clin Transplant. 2017 Nov 29. [Epub ahead of print] doi: 10.1111/ctr.13165
  103. Liuzzi G, Castilletti C, Vairo F, Nicastri E, Ippolito G. Travel-Associated Zika Virus Disease. Ann Intern Med. 2017 Jun 20;166(12):913. doi: 10.7326/L17-0196
  104. Lombardi F, Belmonti S, Quiros-Roldan E, Latini A, Castagna A, D’Ettorre G, Gagliardini R, Fabbiani M, Cauda R, De Luca A, Di Giambenedetto S; AtLaS-M Study Group (… Antinori A, Petrosillo N …). Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial. J Antimicrob Chemother. 2017 Ju1;72(7):2055-2059. doi: 10.1093/jac/dkx068
  105. Lustig Y, Cotar AI, Ceianu CS, Castilletti C, Zelena H, Burdino E, van Tienen C, Avsic T, Aarons E, Reusken C. Lack of Zika virus antibody response in confirmed patients in non-endemic countries. J Clin Virol. 2017 Dec 21;99-100:31-34. [Epub ahead of print] doi: 10.1016/j.jcv.2017.12.007
  106. Madeddu G, Rusconi S, Cozzi-Lepri A, Di Giambenedetto S, Bonora S, Carbone A, De Luca A, Gianotti N, Di Biagio A, Antinori A; Icona Foundation Study Group. Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL. Infection. 2017 Aug;45(4):521-528. Epub 2017 May 5. doi: 10.1007/s15010-017-1018-z
  107. Maggi P, Bellacosa C, Leone A, Volpe A, Ricci ED, Ladisa N, Cicalini S, Grilli E, Viglietti R, Chirianni A, Bellazzi LI, Maserati R, Martinelli C, Corsi P, Celesia BM, Sozio F, Angarano G. Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens – PREVALEAT II cohort. Atherosclerosis. 2017 Aug;263:398-404. Epub 2017 May 5. doi: 10.1016/j.atherosclerosis.2017.05.004
  108. Maggi P, De Socio GV, Cicalini S, D’Abbraccio M, Dettorre G, Di Biagio A, Martinelli C, Nunnari G, Rusconi S, Sighinolfi L, Spagnuolo V, Squillace N. Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians. New Microbiol. 2017 Apr;40(2):139-142. Epub 2017 Jan 10.
  109. Maggi P, Di Biagio A, Rusconi S, Cicalini S, D’Abbraccio M, d’Ettorre G, Martinelli C, Nunnari G, Sighinolfi L, Spagnuolo V, Squillace N. Cardiovascular risk and dyslipidemia among persons living with HIV: a review. BMC Infect Dis. 2017 Aug 9;17(1):551. doi: 10.1186/s12879-017-2626-z
  110. Magis-Escurra C, Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBnet. Treatment outcomes of MDR-TB and HIV co-infection in Europe. Eur Respir J. 2017 Jun 8;49(6). pii: 1602363. Print 2017 Jun. doi: 10.1183/13993003.02363-2016
  111. Maiese A, Del Nonno F, Dell’Aquila M, Moauro M, Baiocchini A, Mastracchio A, Bolino G. Postmortem diagnosis of sepsis: A preliminary immunohistochemical study with an anti-procalcitonin antibody. Leg Med (Tokyo). 2017 Sep;28:1-5. Epub 2017 Ju13. doi: 10.1016/j.legalmed.2017.07.002
  112. Mancone C, Grimaldi A, Refolo G, Abbate I, Rozera G, Benelli D, Fimia GM, Barnaba V, Tripodi M, Piacentini M, Ciccosanti F. Iron overload down-regulates the expression of the HIV-1 Rev cofactor eIF5A in infected T lymphocytes. Proteome Sci. 2017 Aug 4;15:18. eCollection 2017. doi: 10.1186/s12953-017-0126-0
  113. Marchesi F, Spadea A, Pimpinelli F, Prignano G, Paglia MG, Forcella D, Gumenyuk S, Renzi D, Palombi F, Vulcano A, Pisani F, Romano A, Papa E, Facciolo F, Ensoli F, Girmenia C, Mengarelli A. The predictive value of Aspergillus PCR testing on bronchoalveolar lavage fluid for early diagnosis of invasive pulmonary aspergillosis in hematologic patients. Leuk Lymphoma. 2017 Dec;58(12):2943-2946. Epub 2017 May 9. doi: 10.1080/10428194.2017.1315116
  114. Martelli G, Di Girolamo C, Zammarchi L, Angheben A, Morandi M, Tais S, Degani M, El Hamad I, Caligaris S, Ciannameo A, Grilli E, Urbinati L, Monteiro GB, Scarcella C, Petrosillo N, Digaetano M, Rabbi L, Bazzanini N, Cacciatore F, Marta BL, Moro ML, Bartoloni A, Viale P, Verucchi G. Seroprevalence of five neglected parasitic diseases among immigrants accessing five infectious and tropical diseases units in Italy: a cross-sectional study. Clin Microbiol Infect. 2017 May;23(5):335.e1-335.e5. Epub 2017 Mar 1. doi: 10.1016/j.cmi.2017.02.024
  115. Martini S, Donato MF, Mazzarelli C, Rendina M, Visco-Comandini U, Filì D, Gianstefani A, Fagiuoli S, Melazzini M, Montilla S, Pani L, Petraglia S, Russo P, Trotta MP, Carrai P, Caraceni P; for ITACOPS study group. The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience. Liver Int. 2017 Sep 16. [Epub ahead of print] doi: 10.1111/liv.13588
  116. Mazzucotelli V, Piselli P, Verdirosi D, Cimaglia C, Cancarini G, Serraino D, Sandrini S. De novo cancer in patients on dialysis and after renal transplantation: north-western Italy, 1997-2012. J Nephrol. 2017 Dec;30(6):851-857. Epub 2017 Mar 19. doi: 10.1007/s40620-017-0385-y
  117. Mellows B, Mitchell R, Antonioli M, Kretz O, Chambers D, Zeuner MT, Denecke B, Musante L, Ramachandra DL, Debacq-Chainiaux F, Holthofer H, Joch B, Ray S, Widera D, David AL, Huber TB, Dengjel J, De Coppi P, Patel K. Protein and Molecular Characterization of a Clinically Compliant Amniotic Fluid Stem Cell-Derived Extracellular Vesicle Fraction Capable of Accelerating Muscle Regeneration Through Enhancement of Angiogenesis. Stem Cells Dev. 2017 Sep 15;26(18):1316-1333. Epub 2017 Aug 22. doi: 10.1089/scd.2017.0089
  118. Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord (… Antinori A, Girardi E …). Timing of cART initiation in Male and Female Migrants Living with HIV in Western Europe: an observational cohort study (1997-2013). AIDS. 2017 Mar 27;31(6):835-846 doi: 10.1097/QAD.0000000000001411
  119. Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord (… Antinori A, Girardi E …). Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? HIV Med. 2017 Jul 25. [Epub ahead of print] doi: 10.1111/hiv.12536
  120. Nanfack AJ, Takou D, Fokam J, Salpini R, Santoro MM, Cappelli G, Baane M, Tetang SM, Eberle J, Gürtler L, Ceccherini-Silberstein F, Torimiro JN, Colizzi V, Perno CF, Ndjolo A. HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Cross-sectional Design. Curr HIV Res. 2016 Dec 29. [Epub ahead of print]
  121. Nardacci R, Ciccosanti F, Marsella C, Ippolito G, Piacentini M, Fimia GM. Role of autophagy in HIV infection and pathogenesis. J Intern Med. 2017 May;281(5):422-432. Epub 2017 Feb 16. doi: 10.1111/joim.12596
  122. Nguhuni B, De Nardo P, Gentilotti E, Chaula Z, Damian C, Mencarini P, Nicastri E, Fulment A, Piscini A, Vairo F, Aiken AM, Ippolito G. Reliability and validity of using telephone calls for post-discharge surveillance of surgical site infection following caesarean section at a tertiary hospital in Tanzania. Antimicrob Resist Infect Control. 2017 May 8;6:43. eCollection 2017. doi: 10.1186/s13756-017-0205-0
  123. Nicastri E, Brucato A, Petrosillo N, Biava G, Uyeki TM, Ippolito G; INMI’s Ebola Team. Acute rhabdomyolysis and delayed pericardial effusion in an Italian patient with Ebola virus disease: a case report. BMC Infect Dis. 2017 Aug 30;17(1):597. doi: 10.1186/s12879-017-2689-x
  124. Nicastri E, Vairo F, Ippolito G. Discharge Criteria for Patient With Lassa Fever Infection. Clin Infect Dis. 2017 Nov 24. [Epub ahead of print] doi: 10.1093/cid/cix864
  125. Notari S, Tempestilli M, Fabbri G, Libertone R, Antinori A, Ammassari A, Agrati C. UPLC-MS/MS method for the simultneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients. J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Dec 12;1073:183-190. [Epub ahead of print] doi: 10.1016/j.jchromb.2017.12.018
  126. Nozza S, Cozzi-Lepri A, Bai F, Rusconi S, Gori A, Cinque P, Ammassari A, Caramello P, Tambussi G, D’Arminio Monforte A, Marchetti G; Icona Foundation Study Group. Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort. PLoS One. 2017 Dec 5;12(12):e0189045. eCollection 2017. doi: 10.1371/journal.pone.0189045
  127. Odolini S, Gobbi F, Zammarchi L, Migliore S, Mencarini P, Vecchia M, di Lauria N, Schivazappa S, Sabatini T, Chianura L, Vanino E, Piacentini D, Zanotti P, Bussi A, Bartoloni A, Bisoffi Z, Castelli F. Febrile rhabdomyolysis of unknown origin in refugees coming from West Africa through the Mediterranean. Int J Infect Dis. 2017 Sep;62:77-80. Epub 2017 Jul 26. doi: 10.1016/j.ijid.2017.07.018
  128. Orkin C, Llibre JM, Gallien S, Antinori A, Behrens G, Carr A. Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence. HIV Med. 2017 Jul 24. [Epub ahead of print] doi: 10.1111/hiv.12534
  129. Pagani I, Ghezzi S, Ulisse A, Rubio A, Turrini F, Garavaglia E, Candiani M, Castilletti C, Ippolito G, Poli G, Broccoli V, Panina-Bordignon P, Vicenzi E. Human Endometrial Stromal Cells Are Highly Permissive To Productive Infection by Zika Virus. Sci Rep. 2017 Mar 10;7:44286. doi: 10.1038/srep44286
  130. Palucci I, Matic I, Falasca L, Minerva M, Maulucci G, De Spirito M, Petruccioli E, Goletti D, Rossin F, Piacentini M, Delogu G. Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection. J Intern Med. 2017 Dec 4. [Epub ahead of print] doi: 10.1111/joim.12714
  131. Palummieri A, De Carli G, Rosenthal É, Cacoub P, Mussini C, Puro V; PrEPventHIV Italy Study Group. Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians. BMC Infect Dis. 2017 Nov 28;17(1):734. doi: 10.1186/s12879-017-2819-5
  132. Petersen E, Petrosillo N, Koopmans M; ESCMID Emerging Infections Task Force Expert Panel. Emerging Infections are an increasingly important topic. Clin Microbiol Infect. 2017 Nov 15. pii: S1198-743X(17)30641-9. [Epub ahead of print] doi: 10.1016/j.cmi.2017.10.035
  133. Petrone L, Vanini V, Amicosante M, Corpolongo A, Gomez Morales MA, Ludovisi A, Ippolito G, Pozio E, Teggi A, Goletti D. A T-cell diagnostic test for cystic echinococcosis based on Antigen B peptides. Parasite Immunol. 2017 Dec;39(12). doi: 10.1111/pim.12499
  134. Petruccioli E, Scriba TJ, Petrone L, Hatherill M, Cirillo DM, Joosten SA, Codecasa LR, Ottenhoff TH, Denkinger CM, Goletti D. Long-lasting tuberculous pleurisy. Eur Respir J. 2017 May 25;49(5). pii: 1700356. Print 2017 May. doi: 10.1183/13993003.00356-2017
  135. Petruccioli E, Vanini V, Chiacchio T, Cuzzi G, Cirillo DM, Palmieri F, Ippolito G, Goletti D. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis. Tuberculosis (Edinb). 2017 Sep;106:38-43. Epub 2017 Jun 27. doi: 10.1016/
  136. Pittalis S, Orchi N, Carli G, Navarra A, Chiaradia G, Puro V, Girardi E. HIV self-testing in Italy. J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):e84-e85 doi: 10.1097/QAI.0000000000001507
  137. Pittalis S, Piselli P, Contini S, Gualano G, Alma MG, Tadolini M, Piccioni P, Bocchino M, Matteelli A, Bonora S, Di Biagio A, Franzetti F, Carbonara S, Gori A, Sotgiu G, Palmieri F, Ippolito G, Girardi E. Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy. PLoS One. 2017 Dec 18;12(12):e0189425. eCollection 2017. doi: 10.1371/journal.pone.0189425
  138. Ponziani FR, Siciliano M, Lionetti R, Pasquazzi C, Gianserra L, D’Offizi G, Gasbarrini A, Pompili M. Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports. Am J Kidney Dis. 2017 Aug;70(2):297-300. Epub 2017 Mar 1. doi: 10.1053/j.ajkd.2017.01.037
  139. Pozniak A, Flamm J, Antinori A, Bloch M, Ward D, Berenguer J, Cote P, Andreatta K, Garner W, Szwarcberg J, Nguyen-Cleary T, McColl DJ, Piontkowsky D. Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI. HIV Clin Trials. 2017 Jul;18(4):141-148. Epub 2017 Jul 9. doi: 10.1080/15284336.2017.1338844
  140. Pucci L, Massacesi M, Liuzzi G. Clinical management of women with listeriosis risk during pregnancy: a review of national guidelines. Expert Rev Anti Infect Ther. 2017 Dec 13. [Epub ahead of print] doi: 10.1080/14787210.2018.1417837
  141. Raimondo M, Camoni L, Suligoi B, Pezzotti P; CARPHA Study Group (… Antinori A, Giannetti A …). HIV-Positive Individuals on Antiretroviral Therapy and with Viral Load Suppressed in 12 Infectious Diseases Clinics in Italy: Successes and Disparities in the HIV Continuum of Care. AIDS Res Hum Retroviruses. 2017 Mar 6. [Epub ahead of print] doi: 10.1089/AID.2016.0256
  142. Restelli U, Rizzardini G, Antinori A, Lazzarin A, Bonfanti M, Bonfanti P, Croce D. Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients. Ther Clin Risk Manag. 2017 Jun 29;13:787-797. eCollection 2017. doi: 10.2147/TCRM.S135972
  143. Roen A, Laut K, Pelchen-Matthews A, Borodulina E, Caldeira L, Clarke A, Clotet B, d’Arminio Monforte A, Fätkenheuer G, Gatell Artigas JM, Karpov I, Kuznetsova A, Kyselyova G, Mozer-Lisewska I, Mulcahy F, Ragone L, Scherrer A, Uzdaviniene V, Vandekerckhove L, Vannappagari V, Ostergaard L, Mocroft A; EuroSIDA study (… Zaccarelli M, Antinori A, Acinapura R, Plazzi M …). Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort. HIV Med. 2017 Dec 22. [Epub ahead of print] doi: 10.1111/hiv.12573
  144. Rossetti B, Bai F, Tavelli A, Galli M, Antinori A, Castelli F, Pellizzer G, Cozzi-Lepri A, Bonora S, Monforte AD, Puoti M, De Luca A; ICONA Foundation study group. Evolution of the prevalence of HCV infection and HCV genotype distribution in HIV-infected patients in Italy between 1997 and 2015. Clin Microbiol Infect. 2017 Jul 29. pii: S1198-743X(17)30405-6. [Epub ahead of print] doi: 10.1016/j.cmi.2017.07.021
  145. Rossetti B, Gagliardini R, Meini G, Sterrantino G, Colangeli V, Re MC, Latini A, Colafigli M, Vignale F, Rusconi S, Micheli V, Di Biagio A, Orofino G, Ghisetti V, Fantauzzi A, Vullo V, Grima P, Francisci D, Mastroianni C, Antinori A, Trezzi M, Lisi L, Navarra P, Canovari B, D’Arminio Monforte A, Lamonica S, D’Avino A, Zazzi M, Di Giambenedetto S, De Luca A; for GUSTA trial study group. Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial. PLoS One. 2017 Nov 21;12(11):e0187393. eCollection 2017. doi: 10.1371/journal.pone.0187393
  146. Rozera G, Fabbri G, Lorenzini P, Mastrorosa I, Timelli L, Zaccarelli M, Amendola A, Vergori A, Plazzi MM, Cicalini S, Antinori A, Capobianchi MR, Abbate I, Ammassari A. Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals. PLoS One. 2017 Oct 27;12(10):e0187095. eCollection 2017. doi: 10.1371/journal.pone.0187095
  147. Ryom L, Mocroft A, Kirk O, Reiss P, Ross M, Smith C, Moranne O, Morlat P, Fux CA, Sabin C, Phillips A, Law M, Lundgren JD; D:A:D study group (… Narciso P, Zaccarelli M …). Predictors of estimated glomerular filtration rate progression, stabilization or improvement after chronic renal impairment in HIV-positive individuals. AIDS. 2017 Jun 1;31(9):1261-1270. doi: 10.1097/QAD.0000000000001464
  148. Sacchi A, Tumino N, Turchi F, Refolo G, Fimia G, Ciccosanti F, Montalbano M, Lionetti R, Taibi C, D’Offizi G, Casetti R, Bordoni V, Cimini E, Martini F, Agrati C. Dendritic cells activation is associated with sustained virological response to telaprevir treatment of HCV-infected patients. Clin Immunol. 2017 Oct;183:82-90. Epub 2017 Jul 20. doi: 10.1016/j.clim.2017.07.017
  149. Salpini R, Surdo M, Warner N, Cortese MF, Colledge D, Soppe S, Bellocchi MC, Armenia D, Carioti L, Continenza F, Di Carlo D, Saccomandi P, Mirabelli C, Pollicita M, Longo R, Romano S, Cappiello G, Spanò A, Trimoulet P, Fleury H, Vecchiet J, Iapadre N, Barlattani A, Bertoli A, Mari T, Pasquazzi C, Missale G, Sarrecchia C, Orecchini E, Michienzi A, Andreoni M, Francioso S, Angelico M, Verheyen J, Ceccherini-Silberstein F, Locarnini S, Perno CF, Svicher V. Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro. Oncotarget. 2017 Feb 28;8(9):15704-15715. doi: 10.18632/oncotarget.14944
  150. Sañé Schepisi M, Scognamiglio P, D’Amato M, Girardi E, Puro V. Letter to the editor: Trends in tuberculosis notification rates by country of origin in the metropolitan area of Rome, 2010 to 2015. Euro Surveill. 2017 Jul 6;22(27). pii: 30570. doi: 10.2807/1560-7917.ES.2017.22.27.30570
  151. Santangelo L, Battistelli C, Montaldo C, Citarella F, Strippoli R, Cicchini C. Functional Roles and Therapeutic Applications of Exosomes in Hepatocellular Carcinoma. Biomed Res Int. 2017;2017:2931813. Epub 2017 Feb 7. doi: 10.1155/2017/2931813
  152. Santoro MM, Di Carlo D, Armenia D, Zaccarelli M, Pinnetti C, Colafigli M, Prati F, Boschi A, Antoni AMD, Lagi F, Sighinolfi L, Gervasoni C, Andreoni M, Antinori A, Mussini C, Perno CF, Borghi V, Sterrantino G. Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice. Antivir Ther. 2017 Sep 22. Epub ahead of print] doi: 10.3851/IMP3197
  153. Sax PE, Pozniak A, Montes ML, Koenig E, DeJesus E, Stellbrink HJ, Antinori A, Workowski K, Slim J, Reynes J, Garner W, Custodio J, White K, SenGupta D, Cheng A, Quirk E. Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet. 2017 Nov 4;390(10107):2073-2082. Epub 2017 Aug 31 doi: 10.1016/S0140-6736(17)32340-1
  154. Schalkwijk S, Colbers A, Konopnicki D, Gingelmaier A, Lambert J, van der Ende M, Moltó J, Burger D; PANNA Network (… Nicastri E …) . Lowered rilpivirine exposure during third trimester of pregnancy in HIV-1-positive women. Clin Infect Dis. 2017 Oct 15;65(8):1335-1341. doi: 10.1093/cid/cix534
  155. Scognamiglio P, Piselli P, Fusco M, Pisanti FA, Serraino D, Ippolito G, Girardi E; Collaborating Study Group. Declining unawareness of HCV-infection parallel to declining prevalence in Southern Italy. J Med Virol. 2017 Oct;89(10):1691-1692. Epub 2017 May 29. doi: 10.1002/jmv.24840
  156. Scriba TJ, Carpenter C, Pro SC, Sidney J, Musvosvi M, Rozot V, Seumois G, Rosales SL, Vijayanand P, Goletti D, Makgotlho E, Hanekom W, Hatherill M, Peters B, Sette A, Arlehamn CSL. Differential Recognition of Mycobacterium tuberculosis-Specific Epitopes as a Function of Tuberculosis Disease History. Am J Respir Crit Care Med. 2017 Sep 15;196(6):772-781. doi: 10.1164/rccm.201706-1208OC
  157. Selleri M, Dolcetti R, Caccuri F, Giombini E, Rozera G, Abbate I, Mammone A, Zanussi S, Martorelli D, Fiorentini S, Caruso A, Capobianchi MR. In-depth analysis of compartmentalization of HIV-1 matrix protein p17 in PBMC and plasma. New Microbiol. 2017 Jan;40(1):58-61. Epub 2017 Jan 9
  158. .

  159. Shepherd L, Borges ÁH, Harvey R, Bower M, Grulich A, Silverberg M, Weber J, Ristola M, Viard JP, Bogner JR, Gargalianos-Kakolyris P, Mussini C, Mansinho K, Yust I, Paduta D, Jilich D, Smiatacz T, Radoi R, Tomazic J, Plomgaard P, Frikke-Schmidt R, Lundgren J, Mocroft A; EuroSIDA in EuroCOORD (… Zaccarelli M, Antinori A, Acinapura R, Plazzi M …). The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people. HIV Med. 2017 Aug 31. [Epub ahead of print] doi: 10.1111/hiv.12546
  160. Sissoko D, Duraffour S, Kerber R, Kolie JS, Beavogui AH, Camara AM, Colin G, Rieger T, Oestereich L, Pályi B, Wurr S, Guedj J, Nguyen TH, Eggo RM, Watson CH, Edmunds WJ, Bore JA, Koundouno FR, Cabeza-Cabrerizo M, Carter LL, Kafetzopoulou LE, Kuisma E, Michel J, Patrono LV, Rickett NY, Singethan K, Rudolf M, Lander A, Pallasch E, Bockholt S, Rodríguez E, Di Caro A, Wölfel R, Gabriel M, Gurry C, Formenty P, Keïta S, Malvy D, Carroll MW, Anglaret X, Günther S. Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study. Lancet Glob Health. 2017 Jan;5(1):e80-e88. doi: 10.1016/S2214-109X(16)30243-1
  161. Sissoko D, Keïta M, Diallo B, Aliabadi N, Fitter DL, Dahl BA, Akoi Bore J, Raymond Koundouno F, Singethan K, Meisel S, Enkirch T, Mazzarelli A, Amburgey V, Faye O, Alpha Sall A, Magassouba N, Carroll MW, Anglaret X, Malvy D, Formenty P, Bruce Aylward R, Keïta S, Harouna Djingarey M, Loman NJ, Günther S, Duraffour S. Ebola Virus Persistence in Breast Milk After No Reported Illness: A Likely Source of Virus Transmission From Mother to Child. Clin Infect Dis. 2017 Feb 15;64(4):513-516. doi: 10.1093/cid/ciw793
  162. Smit M, Cassidy R, Cozzi-Lepri A, Quiros-Roldan E, Girardi E, Mammone A, Antinori A, Saracino A, Bai F, Rusconi S, Magnani G, Castelli F, Hsue P, d’Arminio Monforte A, Hallett TB. Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study. PLoS One. 2017 Oct 23;12(10):e0186638. eCollection 2017. doi: 10.1371/journal.pone.0186638
  163. Solovic I, Abubakar I, Sotgiu G, Dara M, Goletti D, Duarte R, Aliberti S, de Benedictis FM, Ward B, Teixeira V, Gratziou C, Migliori GB. Standard operating procedures for tuberculosis care. Eur Respir J. 2017 Jun 1;49(6). pii: 1700515. Print 2017 Jun. doi: 10.1183/13993003.00515-2017
  164. Spada E, Rezza G, Garbuglia AR, Lombardo FL, Zuccaro O, Ippolito FM, Cupellaro E, Capone S, Capobianchi MR, Nicosia A, Cortese R, Folgori A, Mele A; Collaborative Study Group. Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy. J Urban Health. 2017 Dec 4. [Epub ahead of print] doi: 10.1007/s11524-017-0207-5
  165. Suligoi B, Regine V, Raimondo M, Rodella A, Terlenghi L, Caruso A, Bagnarelli P, Capobianchi MR, Zanchetta N, Ghisetti V, Galli C. HIV avidity index performance using a modified fourth-generation immunoassay to detect recent HIV infections. Clin Chem Lab Med. 2017 Oct 26;55(12):2010-2019. doi: 10.1515/cclm-2016-1192
  166. Svicher V, Marchetti G, Ammassari A, Ceccherini-Silberstein F, Sarmati L; Impact Study Group. Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success? AIDS Rev. 2017 Oct-Dec;19(3):119-133. doi: 10.24875/AIDSRev.M17000003
  167. Taibi C, Tempestilli M, D’Avolio A, Garbuglia AR, De Nicolò A, Montalbano M, D’Offizi G. Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro-resected patient. J Clin Pharm Ther. 2017 Oct;42(5):621-623. Epub 2017 May 4. doi: 10.1111/jcpt.12546
  168. TB:HIV Study writing Group (… Girardi E …).. One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America. AIDS. 2017 Jan 28;31(3):375-384. doi: 10.1097/QAD.0000000000001333
  169. Tempestilli M, Fabbri G, Mastrorosa I, Timelli L, Notari S, Bellagamba R, Libertone R, Lupi F, Zaccarelli M, Antinori A, Agrati C, Ammassari A. Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real world. J Antimicrob Chemother. 2017 Nov 2. [Epub ahead of print] doi: 10.1093/jac/dkx348
  170. Tumino N, Bilotta MT, Pinnetti C, Ammassari A, Antinori A, Turchi F, Agrati C, Casetti R, Bordoni V, Cimini E, Abbate I, Capobianchi MR, Martini F, Sacchi A. Granulocytic Myeloid-Derived Suppressor Cells Increased in Early Phases of Primary HIV Infection Depending on TRAIL Plasma Level. J Acquir Immune Defic Syndr. 2017 Apr 15;74(5):575-582 doi: 10.1097/QAI.0000000000001283
  171. Tumino N, Casetti R, Fabbri G, Cimini E, Romanelli A, Turchi F, Forini O, Bordoni V, Antinori A, Ammassari A, Sacchi A, Agrati C. In HIV/HCV co-infected patients T regulatory and myeloid-derived suppressor cells persist after successful treatment with directly acting antivirals. J Hepatol. 2017 Aug;67(2):422-424. Epub 2017 Apr 12. doi: 10.1016/j.jhep.2017.03.036
  172. Vairo F, Di Bari V, Panella V, Quintavalle G, Torchia S, Serra MC, Sinopoli MT, Lopalco M, Ceccarelli G, Ferraro F, Valle S, Bordi L, Capobianchi MR, Puro V, Scognamiglio P, Ippolito G, The Outbreak Investigation Group. An outbreak of chickenpox in an asylum seeker centre in Italy: outbreak investigation and validity of reported chickenpox history, December 2015-May 2016. Euro Surveill. 2017 Nov;22(46). doi: 10.2807/1560-7917.ES.2017.22.46.17-00020
  173. Van der Paardt AL, Akkerman OW, Gualano G, Palmieri F, Davies Forsman L, Aleksa A, Tiberi S, de Lange WC, Bolhuis MS, Skrahina A, van Soolingen D, Kosterink JG, Migliori GB, van der Werf TS, Alffenaar JC. Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis. Eur Respir J. 2017 Mar 22;49(3). pii: 1601612. Print 2017 Mar. doi: 10.1183/13993003.01612-2016
  174. Venditti C, Fortini D, Villa L, Vulcano A, D’Arezzo S, Capone A, Petrosillo N, Nisii C, Carattoli A, Di Caro A. Circulation of bla(KPC-3)-Carrying IncX3 Plasmids among Citrobacter freundii Isolates in an Italian Hospital. Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00505-17. Print 2017 Aug. doi: 10.1128/AAC.00505-17
  175. Venditti C, Nisii C, D’Arezzo S, Vulcano A, Di Caro A. Letter to the Editor: Surveillance of mcr-1 and mcr-2 genes in Carbapenem-resistant Klebsiella pneumoniae strains from an Italian Hospital. Euro Surveill. 2017 Aug 31;22(35). pii: 30604. doi: 10.2807/1560-7917.ES.2017.22.35.30604
  176. Viganò M, Perno CF, Craxì A; AdHoc (Advancing Hepatitis C for the Optimization of Cure) Working Party (… D’Offizi G …). Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel. Dig Liver Dis. 2017 Jul;49(7):731-741. Epub 2017 Apr 12. doi: 10.1016/j.dld.2017.03.027
  177. Vincenti D, Piselli P, Solmone M, D’Offizi G, Capobianchi MR, Menzo S. Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002-2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment. Antiviral Res. 2017 Mar 18;143:62-68. [Epub ahead of print] doi: 10.1016/j.antiviral.2017.03.008
  178. Vita S, Lichtner M, Marchetti G, Mascia C, Merlini E, Cicconi P, Vullo V, Viale P, Costantini A, DʼArminio Monforte A; for ICONA Foundation Study Group (… Acinapura R, Ammassari A, Antinori A, Libertone R, Nicastri E …). Brief Report: Soluble CD163 in CMV-Infected and CMV-Uninfected Subjects on Virologically Suppressive Antiretroviral Therapy in the ICONA Cohort. J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):347-352. doi: 10.1097/QAI.0000000000001232
  179. Volpe M, Uglietti A, Castagna A, Mussini C, Marchetti G, Bellagamba R, Bini T, Mancusi D, Termini R. Cardiovascular disease in women with HIV-1 infection. Int J Cardiol. 2017 Aug 15;241:50-56. Epub 2017 Feb 27. doi: 10.1016/j.ijcard.2017.02.117
  180. Vukotic R, Conti F, Fagiuoli S, Morelli MC, Pasulo L, Colpani M, Foschi FG, Berardi S, Pianta P, Mangano M, Donato MF, Malinverno F, Monico S, Tamè M, Mazzella G, Belli LS, Viganò R, Carrai P, Burra P, Russo FP, Lenci I, Toniutto P, Merli M, Loiacono L, Iemmolo R, Degli Antoni AM, Romano A, Picciotto A, Rendina M, Andreone P; AISF-SOFOLT Study group. Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis. J Viral Hepat. 2017 Oct;24(10):858-864. Epub 2017 May 5. doi: 10.1111/jvh.12712
  181. Zumla A, Ippolito G, McCloskey B, Bates M, Ansumana R, Heymann D, Kock R, Ntoumi F. Enhancing preparedness for tackling new epidemic threats. Lancet Respir Med. 2017 Aug;5(8):606-608. Epub 2017 May 18. doi: 10.1016/S2213-2600(17)30189-3
Torna all'inizio dei contenuti